Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study.
Case–control study
Indoor radon
Small cell lung cancer
Tobacco
Journal
Archivos de bronconeumologia
ISSN: 1579-2129
Titre abrégé: Arch Bronconeumol
Pays: Spain
ID NLM: 0354720
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
03
12
2020
revised:
06
01
2021
accepted:
26
01
2021
pubmed:
22
3
2022
medline:
7
7
2022
entrez:
21
3
2022
Statut:
ppublish
Résumé
Residential radon is considered the second cause of lung cancer and the first in never smokers. Nevertheless, there is little information regarding the association between elevated radon levels and small cell lung cancer (SCLC). We aimed to assess the effect of residential radon exposure on the risk of SCLC in general population through a multicentric case-control study. A multicentric hospital-based case-control study was designed including 9 hospitals from Spain and Portugal, mostly including radon-prone areas. Indoor radon was measured using Solid State Nuclear Track Detectors at the Galician Radon Laboratory. A total of 375 cases and 902 controls were included, with 24.5% of cases being women. The median number of years living in the measured dwelling was higher than 25 years for both cases and controls. There was a statistically significant association for those exposed to concentrations higher than the EPA action level of 148Bq/m Radon exposure seems to increase the risk of small cell lung cancer with a linear dose-response pattern. Tobacco consumption may also produce an important effect modification for radon exposure.
Identifiants
pubmed: 35312555
pii: S0300-2896(21)00052-1
doi: 10.1016/j.arbres.2021.01.027
pii:
doi:
Substances chimiques
Radon
Q74S4N8N1G
Types de publication
Journal Article
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
542-546Informations de copyright
Copyright © 2021 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.